arcadia

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE462.10-0.2 (-0.04 %)
PREV CLOSE ( ) 462.30
OPEN PRICE ( ) 462.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 462.10 (292)
VOLUME 238852
TODAY'S LOW / HIGH ( )456.80 466.00
52 WK LOW / HIGH ( )375.4 678.8
NSE463.200.65 (+0.14 %)
PREV CLOSE( ) 462.55
OPEN PRICE ( ) 463.90
BID PRICE (QTY) 463.20 (481)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3567327
TODAY'S LOW / HIGH( ) 456.70 466.00
52 WK LOW / HIGH ( )370.2 679.3
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
11Apr Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed about the disclosure under Re..
11Apr Pratham Investments informs about disc
Pratham Investments has informed about the disclosure under Regulation 3..
09Apr Sun Pharma's arm to commence distribut
Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Dis..
09Apr Sun Pharma trades in green on the BSE
Sun Pharmaceutical Industries is currently trading at Rs. 464.50, up by..
08Apr Sun Pharma launches INFUGEM in US
Sun Pharmaceutical Industries has launched INFUGEM in the US for intrave..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit-386.8-4945.9
Gross Profit -650.7 -5199.8
Operating Profit 2023.712510.6
Net Sales 22612.679476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Hester Biosciences (BSE)
 1487.50 (2.00%)
M.Cap ( in Cr)1265.40
Ipca Laboratories (BSE)
 968.95 (2.98%)
M.Cap ( in Cr)12242.89
Shilpa Medicare (BSE)
 398.70 (5.98%)
M.Cap ( in Cr)3250.48
Fredun Pharma (BSE)
 473.35 (3.60%)
M.Cap ( in Cr)188.85
Themis Medicare (BSE)
 297.45 (3.59%)
M.Cap ( in Cr)273.09
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 13.09%
MUTUAL FUNDS/UTI 9.69%
FI/BANKS/INSURANCE 7.8%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM